In this issue:
Have a question?
If you have needs specifically related to this newsletter's content, send us an email to have a Deloitte Tax professional contact you.
Tax News & Views
The Internal Revenue Service released proposed regulations February 3 addressing the new 2.3 percent excise tax on medical device sales that was enacted in the 2010 health care reform legislation and takes effect beginning January 1, 2013. (For prior coverage on the proposed regulations, see Tax News & Views, Vol. 13, No. 5, Feb. 10, 2012.)
A recent DBriefs webcast from Deloitte Tax LLP looks at issues that affected companies should consider in addressing the new proposed rules, including:
View the playback of this webcast to understand more about the impact of the new proposed regulations on affected companies.
— Michael DeHoff
This publication contains general information only, and none of Deloitte Touche Tohmatsu Limited, its member firms, or its and their affiliates are, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your finances or your business. Before making any decision or taking any action that may affect your finances or your business, you should consult a qualified professional adviser. None of Deloitte Touche Tohmatsu Limited, its member firms, or its and their respective affiliates shall be responsible for any loss whatsoever sustained by any person who relies on this publication.
Deloitte.com | Unsubscribe | Manage E-mail Preferences | RSS